Stay updated on Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page
- CheckyesterdayChange DetectedVersion 44, dated 2026-07-10, added dedicated Contacts/Locations and Study Status sections to the study record, reflecting updated contact details and current trial status. A prior change on 2026-06-15 was a deletion.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 on the Record History page, indicating a new build/version of the page history interface.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page footer now shows Revision: v3.6.2 instead of v3.6.0, reflecting a newer release of the page.SummaryDifference0.1%

- Check29 days agoChange DetectedOn 2026-06-15, the record added new sections for Study Status, Contacts/Locations, and References. The update expands the page with current status details, contact information, and related references.SummaryDifference0.4%

- Check36 days agoChange DetectedTwo new user-facing options were added: 'Check who can join' and 'Find Contact Information', along with a revision tag 'v3.6.0'. These changes provide easier access to eligibility guidance and study contact details within the record.SummaryDifference0.3%

- Check43 days agoChange DetectedA new revision label, v3.5.5, appears on the history page as the latest entry. This marks a minor platform update rather than a change to study content.SummaryDifference0.1%

Stay in the know with updates to Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.